ResearcherNagoya UniversityNo recent work listed
Daishi Morimoto
Matched on OpenAlex author ID A5110539823. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper
Papers 4
- C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells. Co-author DOI 10.3390/cells10061502↗
- Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001559↗
- Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07981-w↗
- Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. Co-author DOI 10.1097/mpa.0000000000001186↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yasuhiro Kodera · 4 shared papers, 2018–2021 · strength 0.37
- Paper C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cell… DOI 10.3390/cells10061502↗
- Paper Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. DOI 10.1097/mpa.0000000000001559↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Mitsuro Kanda · 3 shared papers, 2018–2020 · strength 0.25
- Paper Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. DOI 10.1097/mpa.0000000000001559↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Paper Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. DOI 10.1097/mpa.0000000000001186↗
- Fuminori Sonohara · 3 shared papers, 2018–2020 · strength 0.25
- Paper Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. DOI 10.1097/mpa.0000000000001559↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Paper Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. DOI 10.1097/mpa.0000000000001186↗
- Masamichi Hayashi · 3 shared papers, 2018–2020 · strength 0.25
- Paper Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. DOI 10.1097/mpa.0000000000001559↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Paper Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. DOI 10.1097/mpa.0000000000001186↗
- Suguru Yamada · 3 shared papers, 2018–2020 · strength 0.25
- Paper Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. DOI 10.1097/mpa.0000000000001559↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Paper Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. DOI 10.1097/mpa.0000000000001186↗
- Tsutomu Fujii · 3 shared papers, 2018–2020 · strength 0.25
- Paper Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. DOI 10.1097/mpa.0000000000001559↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Paper Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. DOI 10.1097/mpa.0000000000001186↗
- Ibrahim Ragab Eissa · 1 shared paper, 2021 · strength 0.12
- Hideki Kasuya · 1 shared paper, 2021 · strength 0.12
- Yuki Sunagawa · 1 shared paper, 2020 · strength 0.09
- Masaya Suenaga · 1 shared paper, 2018 · strength 0.06
- Norifumi Hattori · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.